News
Julie Brahmer, MD, discusses the unique features of the phase 3 CheckMate 9LA trial in patients with metastatic non–small cell lung cancer.
The Advanced Practitioner Society for Hematology and Oncology (APSHO) welcomes hematology/oncology advanced practitioners?nurse practitioners and physician assistants from Johns Hopkins Sidney Kimmel ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback